M3 (OTCMKTS:MTHRF) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership and earnings.
Analyst Ratings
This is a breakdown of recent ratings and price targets for M3 and CloudMD Software & Services, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
M3 | 0 | 0 | 3 | 0 | 3.00 |
CloudMD Software & Services | 0 | 0 | 2 | 0 | 3.00 |
CloudMD Software & Services has a consensus price target of $3.3750, suggesting a potential upside of 110.28%. Given CloudMD Software & Services' higher possible upside, analysts clearly believe CloudMD Software & Services is more favorable than M3.
Profitability
This table compares M3 and CloudMD Software & Services' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
M3 | N/A | N/A | N/A |
CloudMD Software & Services | N/A | N/A | N/A |
Valuation & Earnings
This table compares M3 and CloudMD Software & Services' gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
M3 | N/A | N/A | N/A | N/A | N/A |
CloudMD Software & Services | N/A | N/A | N/A | N/A | N/A |